Search

Author/Creator Gasior, Maria

1. A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder. Issue 3 (June 2017)

Authors:
Gasior, Maria; Hudson, James; Quintero, Javier; Ferreira-Cornwell, M. Celeste; Radewonuk, Jana; McElroy, Susan L.
Journal:
Journal of clinical psychopharmacology
Issue:
Volume 37:Issue 3(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive–Compulsive and Impulsive Features in Adults with Binge Eating Disorder. (1st December 2015)

Authors:
McElroy, Susan L.; Mitchell, James E.; Wilfley, Denise; Gasior, Maria; Ferreira‐Cornwell, M. Celeste; McKay, Michael; Wang, Jiannong; Whitaker, Timothy; Hudson, James I.
Journal:
European eating disorders review
Issue:
Volume 24:Number 3(2016:May)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder. Issue 8 (8th May 2017)

Authors:
McElroy, Susan L.; Hudson, James I.; Gasior, Maria; Herman, Barry K.; Radewonuk, Jana; Wilfley, Denise; Busner, Joan
Journal:
International journal of eating disorders
Issue:
Volume 50:Issue 8(2017)
Page Start:
884
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗